Responses
Oral Presentations
Abstract session: SpA and PsA treatment
OP0174 Efficacy and Safety of Ustekinumab in Psoriatic Arthritis Patients with Spondylitis and Peripheral Joint Involvement: Results from a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study
Compose a Response to This Article
Other responses
No responses have been published for this article.